455 related articles for article (PubMed ID: 19608446)
1. Overview of the legal framework applicable to the marker method for the detection of human growth hormone.
Young RR; Bielak JS; Horvitz SL
Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446
[TBL] [Abstract][Full Text] [Related]
2. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
[TBL] [Abstract][Full Text] [Related]
3. Laboratory issues in the implementation of the marker method.
Cowan DA; Bartlett C
Growth Horm IGF Res; 2009 Aug; 19(4):357-60. PubMed ID: 19574074
[TBL] [Abstract][Full Text] [Related]
4. Detection of GH abuse in sport: Past, present and future.
Barroso O; Schamasch P; Rabin O
Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
[TBL] [Abstract][Full Text] [Related]
5. Moving one step closer to catching the GH cheats: The GH-2004 experience.
Holt RI; Bassett EE; Erotokritou-Mulligan I; McHugh C; Cowan D; Bartlett C; Sönksen PH;
Growth Horm IGF Res; 2009 Aug; 19(4):346-51. PubMed ID: 19467613
[TBL] [Abstract][Full Text] [Related]
6. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
Nelson AE; Ho KK
Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
[TBL] [Abstract][Full Text] [Related]
7. IGF-I abuse in sport: current knowledge and future prospects for detection.
Guha N; Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
9. Statistical issues in implementing the marker method.
Bassett EE; Erotokritou-Mulligan I
Growth Horm IGF Res; 2009 Aug; 19(4):361-5. PubMed ID: 19515593
[TBL] [Abstract][Full Text] [Related]
10. The history of doping and growth hormone abuse in sport.
Holt RI; Erotokritou-Mulligan I; Sönksen PH
Growth Horm IGF Res; 2009 Aug; 19(4):320-6. PubMed ID: 19467612
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone abuse: methods of detection.
Rigamonti AE; Cella SG; Marazzi N; Di Luigi L; Sartorio A; Müller EE
Trends Endocrinol Metab; 2005; 16(4):160-6. PubMed ID: 15860412
[TBL] [Abstract][Full Text] [Related]
12. Hormone abuse in sports: the antidoping perspective.
Barroso O; Mazzoni I; Rabin O
Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
[TBL] [Abstract][Full Text] [Related]
13. GH & IGF Research issue on doping with growth hormone.
Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):283-4. PubMed ID: 19535276
[No Abstract] [Full Text] [Related]
14. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor I and procollagen type III peptide.
Abellan R; Ventura R; Pichini S; Di Giovannandrea R; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2006 Dec; 27(12):976-83. PubMed ID: 16612742
[TBL] [Abstract][Full Text] [Related]
15. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
Kniess A; Ziegler E; Thieme D; Müller RK
J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
[TBL] [Abstract][Full Text] [Related]
16. The UK Sport perspective on detecting growth hormone abuse.
Stow MR; Wojek N; Marshall J
Growth Horm IGF Res; 2009 Aug; 19(4):375-7. PubMed ID: 19487144
[TBL] [Abstract][Full Text] [Related]
17. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
[TBL] [Abstract][Full Text] [Related]
18. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
Barroso O; Handelsman DJ; Strasburger C; Thevis M
Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
[TBL] [Abstract][Full Text] [Related]
19. 20K-GH and its use in detecting GH abuse.
Irie M; Ueki M; Kishikawa Y; Nishii M; Kawahara T
Growth Horm IGF Res; 2009 Aug; 19(4):352-6. PubMed ID: 19487145
[TBL] [Abstract][Full Text] [Related]
20. A false start in the race against doping in sport: concerns with cycling's biological passport.
Hailey N
Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
